Cefpodoxime ProxetilThird Party Manufacturing in India

Cefpodoxime Proxetil is an orally administered prodrug that is de-esterified in the intestinal mucosa to release its active metabolite, cefpodoxime. Cefpodoxime is a third-generation cephalosporin that exerts its bactericidal effect by binding to specific penicillin-binding proteins located in the bacterial cytoplasmic membrane. This binding inhibits the transpeptidase enzymes responsible for cross-linking the peptidoglycan chains that form the structural backbone of the bacterial cell wall. Without proper cross-linking, the cell wall becomes weak and unable to maintain its structural integrity, causing the bacteria to undergo lysis and die.

Cefpodoxime exhibits broad-spectrum activity against both Gram-positive and Gram-negative bacteria. It is particularly effective against respiratory pathogens such as Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Its resistance to hydrolysis by many beta-lactamases gives it an advantage over earlier generation cephalosporins. The prodrug design of Cefpodoxime Proxetil improves oral absorption compared to the parent compound, with food enhancing its bioavailability. Once absorbed, it distributes well into various tissues including the respiratory mucosa, tonsils, and middle ear fluid, making it suitable for upper and lower respiratory tract infections.

Therapeutic Uses

Cefpodoxime Proxetil is prescribed for the treatment of:

• Upper Respiratory Tract Infections: Effective for pharyngitis, tonsillitis, sinusitis, and acute otitis media caused by susceptible strains of Streptococcus pyogenes, Streptococcus pneumoniae, and Haemophilus influenzae.
• Lower Respiratory Tract Infections: Used for community-acquired pneumonia, acute bronchitis, and acute exacerbations of chronic bronchitis.
• Uncomplicated Urinary Tract Infections: Effective against cystitis and other UTIs caused by Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis.
• Skin and Soft Tissue Infections: Active against uncomplicated skin infections including furuncles, cellulitis, and wound infections.
• Uncomplicated Gonorrhea: Used as an oral alternative for the treatment of urethral and cervical gonorrhea.

Why Manufacturers Choose Cefpodoxime Proxetil

Cefpodoxime Proxetil is among the most widely manufactured third-generation oral cephalosporins in India. Its broad spectrum of activity, excellent safety profile, and convenient twice-daily dosing make it a staple in antibiotic portfolios. The molecule is available in multiple strengths from 50mg to 200mg tablets, allowing manufacturers to serve diverse market segments. Indian manufacturers supply Cefpodoxime Proxetil to domestic PCD networks and export to over 50 countries. Its inclusion in the WHO Essential Medicines List and multiple treatment guidelines ensures sustained prescribing demand, making it a reliable molecule for contract manufacturing operations.